药品专利反向支付协议反垄断分析模式的重构——以我国首例反向支付协议审查案为中心  

Reconstruct the antitrust analysis model of pharmaceutical patent reverse payment settlement agreements:focusing on the first case of anti-monopoly review

作　　者：王欣辰 葛章志[1,2] WANG Xin-chen;GE Zhang-zhi(Institute of Intellectual Property,University of Science and Technology of China,Hefei 230026,China;School of Public Affairs,University of Science and Technology of China,Hefei 230026,China)

机构地区：[1]中国科学技术大学知识产权研究院,合肥230026 [2]中国科学技术大学公共事务学院,合肥230026

出　　处：《中国新药杂志》2023年第13期1293-1301,共9页Chinese Journal of New Drugs

基　　金：国家社会科学基金资助项目(19BFX129)。

摘　　要：“首例反向支付协议审查案”的落槌,标志着药品专利反向支付协议的涉垄断问题正式进入我国有关部门的视野。然而,任何单一的分析模式均难以准确识别药品专利反向支付协议的违法性,占据主流的合理原则概莫能外。最高人民法院在该案中运用的混合分析模式兼具可塑性和确定性,有望成为我国规制药品专利反向支付协议的新范式。鉴于此,本文从最高人民法院的审理思路出发,梳理了该模式在效果分析、效力审查和豁免条款方面的难点,并依据药品专利反向支付协议的特性和我国知识产权反垄断领域的规则提出了矫正和完善的建议。Since the first anti-monopoly review case was completed,public authorities are starting to pay more attention to reverse payment settlement agreements.However,it is extremely problematic for any single mode of analysis to accurately identify the illegality of reverse payment settlement agreements,not excluding the rule of reason.On the contrary,the hybrid modes of analysis applied by the Supreme Court in this case is both flexible and definitive,which is expected to become a new paradigm in China.In view of this,this article analyzes the trial thinking of the Supreme Court,and summarizes the difficulties of the case in terms of the effect analysis,validity review and exemption clause.Finally,based on the characteristics of reverse payment settlement agreements and the antitrust rules in intellectual property field of China,this article makes suggestions to improve the mode of analysis.

关 键 词：反向支付 药品专利 反垄断审查 混合分析方法 

分 类 号：R95[医药卫生—药学]